Meta Can Absorb Capex Trouble, That Is Why I Am Buying This Week

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • Meta's ad engine posted $56B in Q1 revenue, up 33%, with a 41% operating margin strong enough to absorb annual capex in the range of $125B to $145B.

  • META's 41% operating margin and 30% ROE outperform GOOGL, while SNAP's tiny scale can't rival Meta's 3.56B daily active users.

  • Free cash flow grew 12% to $12B even as capex jumped 47%, confirming Meta funds its AI buildout from operational strength.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Meta didn't make the cut. Grab the names FREE today.

Meta Can Absorb Capex Trouble, That Is Why I Am Buying This Week

© dcampiglia / iStock

I hit the buy button on Meta Platforms (NASDAQ:META | META Price Prediction) again last week, and I will hit it again this week if the capex conversation around Wednesday’s earnings knocks the stock down further. That is the confession. The company keeps handing me evidence that its core engine is stronger than the headline noise around AI spending, and I keep responding by adding shares.

What pulls me back is simple. Meta owns the largest connected audience in human history and monetizes it at margins most industrial companies only dream about. In Q1 2026, family daily active people reached 3.56B. That is the audience. Ad impressions grew 19% year over year and the average price per ad grew 12%. Both dials turning at once is the reason my thesis stays intact.

Three Pillars Under the Buy Button

First, the ad engine. Q1 2026 revenue came in at $56.31B, up 33.1% YoY, with EPS of $10.44 beating the $6.66 estimate for the fifth straight beat. Operating income grew to $22.87B and the operating margin held at 41.4%. Advertising revenue of $55.02B is doing the heavy lifting while Reality Labs’ $4.03B quarterly loss barely dents the P&L.

Second, the balance sheet. Debt/equity sits at 0.386. Interest coverage is 71.5x. Cash on hand: $23.43B against $395.25B in assets. ROE is 30.24%, ROIC 20.69%. When a company tells me it plans to spend $125B to $145B on capex in a single year, I want to see it can absorb execution stumbles without financial strain. Meta can.

Third, capital return. FY2025 buybacks totaled $26.25B and the quarterly dividend of $0.53 runs roughly $1.34B per quarter. An FCF yield of 3.53% keeps real cash flowing back to owners while the AI buildout runs.

Why Meta and Not the Obvious Alternatives

I already own Alphabet (NASDAQ:GOOGL) and passed on adding more because Meta’s operating margin of 41.4% and ROE of 30.24% deliver a cleaner return-on-capital profile than any other ad-supported name I hold. I looked at Snap (NYSE:SNAP) and could not build a case that competes with Meta’s 3.56B daily active people scale advantage. On the AI valuation debate, Polymarket’s crowd assigns 82% odds that Meta finishes 2026 with a higher valuation than OpenAI. The market already believes the incumbent wins this stretch of the race.

The Real Risk

The risk is capex, plainly stated. Full-year 2026 capex was raised to $125B to $145B from $115B to $135B, citing higher component pricing and data center costs. After the Q4 2025 report, shares dropped 8.55% on earnings day when the initial capex bomb landed. The one-week move of -7.87% into this week’s Q2 report shows the market rehearsing that trade again. I take the risk seriously. What keeps me buying is that Q1 2026 free cash flow still grew 11.7% to $12.39B while capex jumped 46.8%. Meta is spending from a position of operational strength.

What Keeps the Buy Button Active

This remains a compounder trading at a P/E of 22, with a 3.56B-person audience, a 41.4% operating margin, and a balance sheet that can absorb every dollar of AI spend without touching the dividend or the buyback. I will keep buying until one of those numbers breaks.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

WDAY Vol: 2,121,361
CSGP Vol: 2,873,395
TSN Vol: 2,240,737
TYL Vol: 233,692
ADSK Vol: 778,756

Top Losing Stocks

CTRA Vol: 73,319,495
AMD
AMD Vol: 17,010,169
LRCX Vol: 5,913,699
AMAT Vol: 3,986,817
TER Vol: 1,455,736